# A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity

> **NCT00236613** · PHASE2 · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 385 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** topiramate

## Key facts

- **NCT ID:** NCT00236613
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-09
- **Primary completion:** —
- **Final completion:** 2001-07
- **Target enrollment:** 385 (ACTUAL)
- **Last updated:** 2010-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00236613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00236613, "A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00236613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*